Anthrax other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Diagnostic Studies==
==Diagnostic Studies==
Other studies to diagnose Anthrax infection include:<ref name="HendricksWright2014">{{cite journal|last1=Hendricks|first1=Katherine A.|last2=Wright|first2=Mary E.|last3=Shadomy|first3=Sean V.|last4=Bradley|first4=John S.|last5=Morrow|first5=Meredith G.|last6=Pavia|first6=Andy T.|last7=Rubinstein|first7=Ethan|last8=Holty|first8=Jon-Erik C.|last9=Messonnier|first9=Nancy E.|last10=Smith|first10=Theresa L.|last11=Pesik|first11=Nicki|last12=Treadwell|first12=Tracee A.|last13=Bower|first13=William A.|title=Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults|journal=Emerging Infectious Diseases|volume=20|issue=2|year=2014|issn=1080-6040|doi=10.3201/eid2002.130687}}</ref>
Other studies to diagnose and monitor [[Anthrax]] [[infection]] and its potencial [[complications]] include:<ref name="HendricksWright2014">{{cite journal|last1=Hendricks|first1=Katherine A.|last2=Wright|first2=Mary E.|last3=Shadomy|first3=Sean V.|last4=Bradley|first4=John S.|last5=Morrow|first5=Meredith G.|last6=Pavia|first6=Andy T.|last7=Rubinstein|first7=Ethan|last8=Holty|first8=Jon-Erik C.|last9=Messonnier|first9=Nancy E.|last10=Smith|first10=Theresa L.|last11=Pesik|first11=Nicki|last12=Treadwell|first12=Tracee A.|last13=Bower|first13=William A.|title=Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults|journal=Emerging Infectious Diseases|volume=20|issue=2|year=2014|issn=1080-6040|doi=10.3201/eid2002.130687}}</ref>


{| style="border: 2px solid #DCDCDC; font-size: 90%"
{| style="border: 2px solid #DCDCDC; font-size: 90%"

Revision as of 00:40, 17 July 2014

Anthrax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Anthrax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anthrax other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anthrax other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anthrax other diagnostic studies

CDC on Anthrax other diagnostic studies

Anthrax other diagnostic studies in the news

Blogs on Anthrax other diagnostic studies

Directions to Hospitals Treating Anthrax

Risk calculators and risk factors for Anthrax other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Diagnostic Studies

Other studies to diagnose and monitor Anthrax infection and its potencial complications include:[1]

Laboratory findings
Test Initial Findings Serial Monitoring
EKG Atrial fibrillation with rapid ventricular response
Lumbar puncture At admission unless contraindicated Headache
Confusion
Other neurologic symptom
If meningitis, meningeal signs will only be present at a later stage
Other imaging As relevant to site of exposure
Evaluate edema
Evaluate inflammation
Evaluate necrosis
For headache, confusion or other neurologic symptom
If meningitis, meningeal signs will only be present at a later stage
Echocardiogram Evaluate for pericardial effusion
Evaluate for myocardial dysfunction

PCR

PCR is becoming more widely available as a means of confirming the presence of the virulence factor (capsule and toxin) genes, and hence that an isolate is, or is not, virulent B. anthracis. For routine purposes, primers to one of the toxin genes (usually the Protective Antigen gene) and to one of the enzymes mediating capsule formation are adequate. In laboratories not equipped for PCR tests, if doubt remains to the definitive identity of a suspect B. anthracis isolate, inoculation into a mouse or guinea-pig may be the only way remaining to determine conclusively if it is virulent B. anthracis. However this should be a last resort procedure and confined to situations where a definitive identification is essential.


References

  1. Hendricks, Katherine A.; Wright, Mary E.; Shadomy, Sean V.; Bradley, John S.; Morrow, Meredith G.; Pavia, Andy T.; Rubinstein, Ethan; Holty, Jon-Erik C.; Messonnier, Nancy E.; Smith, Theresa L.; Pesik, Nicki; Treadwell, Tracee A.; Bower, William A. (2014). "Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults". Emerging Infectious Diseases. 20 (2). doi:10.3201/eid2002.130687. ISSN 1080-6040.